HOW GLP-1 MEDICATIONS WORK
How GLP-1 Medications Work — Receptors, Appetite, and Why the Dose Climbs
By G1 Peptides · Medically reviewed by the G1 Peptides clinical team · Updated September 24, 2026 · 3 min read
THE SHORT ANSWER
GLP-1 is a gut hormone released after meals that tells the brain you are full, slows the stomach, and helps the pancreas release insulin. GLP-1 medications are long-acting copies of that signal, so the hormone that normally lasts minutes lasts a week. The result is less hunger and earlier fullness; the cost is digestive side effects, which is why the dose is raised in steps over months.
The hormone
Glucagon-like peptide-1 is made by cells in the lining of the small intestine and released within minutes of eating. It does three things at once (Drucker 2018):
- Tells the pancreas to release insulin — but only when glucose is high, which is why GLP-1 drugs rarely cause low blood sugar on their own.
- Slows stomach emptying, so a meal stays in the stomach longer and you feel full sooner and for longer.
- Signals the brain — the hypothalamus and brainstem — to reduce hunger and, in many people, the reward value of food.
Natural GLP-1 is destroyed by an enzyme (DPP-4) within about two minutes. That short life is the whole problem the drugs solve.
The drugs
Semaglutide, tirzepatide, and retatrutide are analogs: modified versions of the hormone, engineered with amino-acid substitutions and a fatty-acid side chain that binds to albumin in the blood. The fatty acid is the trick — it lets the molecule ride on albumin, hidden from DPP-4 and the kidneys, for about a week. One injection, seven days of signal.
The generations differ in which receptors they hit:
| Drug | Receptors | Extra effect |
|---|---|---|
| Semaglutide | GLP-1 | — |
| Tirzepatide | GLP-1 + GIP | GIP adds to the insulin and appetite effect; may blunt nausea |
| Retatrutide | GLP-1 + GIP + glucagon | Glucagon adds energy expenditure and liver-fat effects |
Each added receptor has, so far, meant more weight loss in trials — semaglutide averaged about 15% over 68 weeks in STEP 1 (Wilding 2021), tirzepatide about 20%, retatrutide about 24% in phase 2. The compounds compared goes into detail.
Why the dose starts low
Slowed stomach emptying is the mechanism and also the main side effect. Turn it up too fast and the stomach holds food long enough to cause nausea, reflux, and vomiting. Start low and the gut adapts — the slowing effect on gastric emptying actually diminishes with continued use, while the appetite effect persists.
So every protocol escalates: semaglutide from 0.25 mg to 2.4 mg over about four months, tirzepatide from 2.5 mg to as much as 15 mg in 2.5 mg steps. The starting doses are deliberately sub-therapeutic — they exist to let the gut adjust, not to cause weight loss. Dosing and titration walks through the schedules.
What happens in the body over months
- Weeks 1–4: appetite drops noticeably; nausea is most likely here; weight loss is modest.
- Months 2–4: dose steps continue; most of the early weight loss happens; side effects usually fade between steps.
- Months 4–12: maintenance dose; weight loss continues more slowly and plateaus somewhere between months 9 and 15 in the trials.
- Beyond: the maintenance dose holds the result. Stopping returns appetite to baseline.
Blood pressure, triglycerides, liver fat, and HbA1c typically improve alongside weight. Muscle is lost with fat unless protected — see preserving muscle on GLP-1s.
FREQUENTLY ASKED
Do GLP-1 drugs speed up metabolism?
Not meaningfully. Their effect is on intake — appetite, fullness, and food preference — not on calories burned. Weight loss comes from eating less without the constant hunger that usually undermines dieting. Dual and triple agonists that add glucagon (retatrutide, survodutide) do add a modest energy-expenditure effect.
Why does the weight come back if I stop?
The drug replaces a signal; it does not reset the underlying biology. When the signal stops, appetite returns to baseline. Trials that withdrew semaglutide saw most of the lost weight regained within a year, which is why providers talk about maintenance dosing rather than a fixed course.
Is the effect only about willpower?
No. GLP-1 receptors in the hypothalamus and brainstem change the hunger signal itself, and the slowed stomach changes how quickly you feel full. People describe "food noise" going quiet — that is receptor pharmacology, not discipline.
SOURCES
This article is educational and is not medical advice. Peptides are prescription medications; whether any of them is appropriate for you is a decision for a licensed provider who knows your history.